3//SEC Filing
Ysios BioFund I FCR 3
Accession 0001179110-17-010498
CIK 0001479419other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:32 PM ET
Size
20.7 KB
Accession
0001179110-17-010498
Insider Transaction Report
Form 3
Ysios BioFund I FCR
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (666,670 underlying)Series C Preferred Stock
→ Common Stock (62,721 underlying)
Footnotes (2)
- [F1]The Series B Convertible Preferred Stock is convertible into Common Stock on a 5.2083-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F2]The Series C Convertible Preferred Stock is convertible into Common Stock on a 5.2083-for-one basis into the number of shares of Common Stock shown in column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
IncorporatedSpain
Related Parties
1- filerCIK 0001711008
Filing Metadata
- Form type
- 3
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 5:32 PM ET
- Size
- 20.7 KB